Lazard Asset Management
TWST icon

Lazard Asset Management’s Twist Bioscience TWST Stock Holding History

Lazard Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.68M Sell
35,750
-21,878
-38% -$1.42M 0.01% 722
2026
Q1 		$2.74M Sell
57,628
-8,399
-13% -$377K ﹤0.01% 764
2025
Q4 		$2.09M Sell
66,027
-12,323
-16% -$384K ﹤0.01% 846
2025
Q3 		$2.2M Buy
78,350
+20,039
+34% +$607K ﹤0.01% 828
2025
Q2 		$2.14M Sell
58,311
-837
-1% -$28.9K ﹤0.01% 994
2025
Q1 		$2.32M Buy
59,148
+31,267
+112% +$1.41M ﹤0.01% 920
2024
Q4 		$1.29M Buy
27,881
+7,827
+39% +$354K ﹤0.01% 1040
2024
Q3 		$905K Buy
20,054
+15,257
+318% +$726K ﹤0.01% 1122
2024
Q2 		$235K Buy
+4,797
New +$196K ﹤0.01% 1510
2023
Q1 		– Sell
-1,498
Closed -$35K – 2557
2022
Q4 		$35K Sell
1,498
-3,047
-67% -$88.4K ﹤0.01% 1960
2022
Q3 		$160K Buy
4,545
+1,877
+70% +$79.7K ﹤0.01% 1324
2022
Q2 		$93K Buy
2,668
+1,071
+67% +$37.9K ﹤0.01% 1533
2022
Q1 		$78K Buy
1,597
+676
+73% +$37.5K ﹤0.01% 1516
2021
Q4 		$71K Buy
921
+70
+8% +$7.18K ﹤0.01% 1582
2021
Q3 		$91K Sell
851
-49
-5% -$5.61K ﹤0.01% 1450
2021
Q2 		$119K Buy
+900
New +$105K ﹤0.01% 1303
2021
Q1 		– Sell
-1,358
Closed -$191K – 2030
2020
Q4 		$191K Sell
1,358
-645
-32% -$71.6K ﹤0.01% 1105
2020
Q3 		$152K Sell
2,003
-633
-24% -$39.4K ﹤0.01% 986
2020
Q2 		$119K Sell
2,636
-1,993
-43% -$71.5K ﹤0.01% 982
2020
Q1 		$141K Buy
4,629
+3,556
+331% +$95.6K ﹤0.01% 947
2019
Q4 		$22K Buy
+1,073
New +$25.1K ﹤0.01% 1211

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Lazard Asset Management's TWST Position: Q2 2026 in Review

Lazard Asset Management reduced its Twist Bioscience (TWST) stake by 38% in Q2 2026, selling an estimated $1.42M and leaving 35,750 shares worth $3.68M. The position accounts for 0.01% of the portfolio, ranked #722.

Lazard Asset Management first reported a position in TWST in Q4 2019 and has held it in 21 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Lazard Asset Management held 35,750 shares of Twist Bioscience worth $3.68M as of Q2 2026.
  • Lazard Asset Management sold 21,878 Twist Bioscience shares in Q2 2026, an estimated $1.42M.
  • Twist Bioscience made up 0.01% of Lazard Asset Management's portfolio in Q2 2026, its #722 holding.
  • Lazard Asset Management first reported a position in Twist Bioscience in Q4 2019 and has held it in 21 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.